The mechanism and tumorigenesis of oncogenic DNA virus integration

Progress in Biochemistry and Biophysics

Volumn 41, Issue 4, 2014, Pages 324-331

  Yu, Zheng Yuan ^a   Song, Ya Li ^a   Gong, Zhao Jian ^a   Zeng, Zhao Yang ^a   Lu, Jian Hong ^a   Li, Xiao Ling ^a   Xiong, Wei ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Genome; Integration; Oncogenic DNA virus; The next generation sequence technology; Tumor

Indexed keywords

EID: 84904172148     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00554     Document Type: Review

References (76)

1. Bhat P, Mattarono S R, Gosmann C, et al. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev, 2011, 239(1): 85-98
2. Graviti P E. The known unknowns of HPV natural history. J Clin Invest, 2011, 121(12): 4593-4599
3. Lynch J P, 3rd, Fishbein M, Echavarria M. Adenovirus. Semin Respir Crit Care Med, 2011, 32(4): 494-511
4. Tsao S W, Tsang C M, Pang P S, et al. The biology of EBV infection in human epithelial cells. Semin Cancer Biol, 2012, 22(2): 137-143
5. White R E, Ramer P C, Naresh K N, et al. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest, 2012, 122(4): 1487-1502
6. Torres H A, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol, 2012, 9(3): 156-166
7. Roth J R, Andersson D I. Poxvirus use a "gene accordion" to tune out host defenses. Cell, 2012, 150(4): 671-672
8. Boshoff C. Ephrin receptor: a door to KSHV infection. Nat Med, 2012, 18(6): 861-863
9. Yoo J Y, Pradarelli J, Haseley A, et al. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clin Cancer Res, 2012, 18(18): 4931-4941
10. Kasman L, Onicescu G, Voelkel-Johnson C. Histone deacetylase inhibitors restore cell surface expression of the coxsackie adenovirus receptor and enhance CMV promoter activity in castration-resistant prostate cancer cells. Prostate Cancer, 2012, 2012: 137163
11. Sabbah S, Jagne Y J, Zuo J, et al. T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+T cells. Blood, 2012, 119(9): 2083-2092
12. Zhang T, Zhang J, You X, et al. Hepatitis B virus X protein (HBx) modulates oncogene YAP via CREB to promote growth of hepatoma cells. Hepatology, 2012, 56(6): 2051-2059
13. Hsu C H, Peng K L, Jhang H C, et al. The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. Oncogene, 2012, 31(18): 2335-2349
14. Lavorgna A, Harhaj E W. EBV LMP1: New and shared pathways to NF-kappaB activation. Proc Natl Acad Sci USA 2012, 109(7): 2188-2189
15. Mcclellan M J, Khasnis S, Wood C D, et al. Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements. J Virol, 2012, 86(9): 5165-5178
16. Dall K L, Scarpini C G, Roberts I, et al. Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res, 2008, 68(20): 8249-8259
17. Hafner N, Driesch C, Gajda M, et al. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene, 2008, 27(11): 1610-1617
18. Kalantari M, Villa L L, Calleja-Macias I E, et al. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer, 2008, 123(8): 1832-1840
19. Kraus I, Driesch C, Vinokurova S, et al. The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res, 2008, 68(7): 2514-2522
20. Narisawa-Saito M, Yoshimatsu Y, Ohno S, et al. An in vitro multistep carcinogenesis model for human cervical cancer. Cancer Res, 2008, 68(14): 5699-5705
21. Peter M, Stransky N, Couturier J, et al. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol, 2010, 221(3): 320-330
22. Schmitz M, Driesch C, Beer-Grondke K, et al. Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer, 2012, 131(5): E593-602
23. Takakuwa T, Luo W J, Ham M F, et al. Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression. Am J Pathol, 2004, 164 (3): 967-974
24. Theelen W, Speel E J, Herfs M, et al. Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay. Am J Pathol, 2010, 177(4): 2022-2033
25. Williams V M, Filippova M, Soto U, et al. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol, 2011, 6(1): 45-57
26. Yhim H Y, Lee N R, Song E K, et al. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer, 2011, 129(7): 1752-1760
27. Zhang K, Li J T, Li S Y, et al. Integration of human papillomavirus 18 DNA in esophageal carcinoma 109 cells. World J Gastroenterol, 2011, 17(37): 4242-4246
28. Kadaja M, Isok-Paas H, Laos T, et al. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog, 2009, 5(4): e1000397
29. Koike K. Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett, 2009, 286(1): 60-68
30. Mason W S, Low H C, Xu C, et al. Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J Virol, 2009, 83(17): 8396-8408
31. Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res, 2008, 68(1): 307-313
32. Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett, 2009, 286(1): 52-59
33. Feitelson M A, Reis H M, Tufan N L, et al. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Cancer Lett, 2009, 286(1): 69-79
34. Campitelli M, Jeannot E, Peter M, et al. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One, 2012, 7(8): e43393
35. Das P, Thomas A Mahantshetty U, et al. HPV Genotyping and site of viral integration in cervical cancers in Indian women. PLoS One, 2012, 7(7): e41012
36. Ekeowa-Anderson A L, Purdie K J, Gibbon K, et al. AKT1 loss correlates with episomal HPV16 in vulval intraepithelial neoplasia. PLoS One, 2012, 7(6): e38608
37. Gray E, Pett M R, Ward D, et al. In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res, 2010, 70(10): 4081-4091
38. Ho C M, Lee B H, Chang S F, et al. Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. Virus Res, 2011, 161(2): 124-130
39. Lace M J, Anson J R, Klussmann J P, et al. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J Virol, 2011, 85(4): 1645-1654
40. Winder D M, Pett M R, Foster N, et al. An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol, 2007, 213(1): 27-34
41. Jiang Z S, Jhunjhunwala S, Liu J, et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res, 2012, 22(4): 593-601
42. Ikuta K, Ding M, Zhang F, et al. Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus. J Virol, 2011, 85(15): 7634-7643
43. Kim S H, Koo B S, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer, 2007, 120(7): 1418-1425
44. Peter M, Rosty C, Couturier J, et al. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene, 2006, 25(44): 5985-5993
45. Nakanishi G, Fujii K, Asagoe K, et al. Human papillomavirus genome integration in multifocal vulvar Bowen's disease and squamous cell carcinoma. Clin Exp Dermatol, 2009, 34(8): e965-967
46. Paterlini-Brechot P, Saigo K, Murakami Y, et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene, 2003, 22(25): 3911-3916
47. Gozuacik D, Murakami Y, Saigo K, et al. Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene, 2001, 20(43): 6233-6240
48. Sung W K, Zheng H, Li S, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet, 2012, 44(7): 765-769
49. Saigo K, Yoshida K, Ikeda R, et al. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum Mutat, 2008, 29(5): 703-708
50. Etemadmoghadam D, George J, Cowin P A, et al. Amplicon- dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. PLoS One, 2010, 5(11): e15498
51. Snijders A M, Nowee M E, Fridlyand J, et al. Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma. Oncogene, 2003, 22 (27): 4281-4286
52. Gao J M, Luo X, Tang K, et al. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). J Virol Methods, 2006, 136(1-2): 193 199
53. Jayshree R S, Sridhar H, Devi G M. Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study. Cancer, 2003, 99(1): 63-67
54. Wang Y, Lau S H, Sham J S, et al. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene, 2004, 23(1): 142-148
55. Simon D, Carr B I. Integration of hepatitis B virus and alteration of the 1p36 region found in cancerous tissue of primary hepatocellular carcinoma with viral replication evidenced only in noncancerous, cirrhotic tissue. Hepatology, 1995, 22(5): 1393-1398
56. Luo W J, Takakuwa T, Ham M F, et al. Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2). Lab Invest, 2004, 84(9): 1193-1199
57. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science, 2008, 319(5866): 1096-1100
58. Bras J, Guerreiro R, Hardy J. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci, 2012, 13(7): 453-464
59. Treangen T J, Salzberg S L. Repetitive DNA and next-generation sequencing: computational challenges and solutions. Nat Rev Genet, 2012, 13(1): 36-46
60. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet, 2010, 11(10): 685-696
61. Hawkins R D, Hon G C, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet, 2010, 11(7): 476-486
62. Metzker M L. Sequencing technologies - the next generation. Nat Rev Genet, 2010, 11(1): 31-46
63. Tran B, Brown A M, Bedard P L, et al. Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial. Int J Cancer, 2013, 132(7): 1547-1555
64. Carneiro M O, Russ C, Ross M G, et al. Pacific biosciences sequencing technology for genotyping and variation discovery in human data. BMC Genomics, 2012, 13(1): 375
65. Quail M A, Smith M, Coupland P, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 2012, 13: 341
66. Zhang X, Davenport K W, Gu W, et al. Improving genome assemblies by sequencing PCR products with PacBio. Biotechniques, 2012, 53(1): 61-62
67. Glenn T C. Field guide to next-generation DNA sequencers. Mol Ecol Resour, 2011, 11(5): 759-769
68. Zhao J, Grant S F. Advances in whole genome sequencing technology. Curr Pharm Biotechnol, 2011, 12(2): 293-305
69. McCarthy A. Third generation DNA sequencing: pacific biosciences' single molecule real time technology. Chem Biol, 2010, 17(7): 675-676
70. Korlach J, Bjornson K P, Chaudhuri B P, et al. Real-time DNA sequencing from single polymerase molecules. Methods Enzymol, 2010, 472: 431-455
71. Iorio M V, Croce C M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med, 2012,4(3): 143-159
72. Pritchard C C, Cheng H H, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet, 2012, 13(5): 358-369
73. Wang L, Wang J. MicroRNA-mediated breast cancer metastasis: from primary site to distant organs. Oncogene, 2012, 31 (20): 2499-2511
74. Pan Y F, Feng L, Zhang X Q, et al. Role of long non-coding RNAs in gene regulation and oncogenesis. Chin Med J (Engl), 2011, 124(15): 2378-2383
75. Morris K V, Vogt P K. Long antisense non-coding RNAs and their role in transcription and one ogenesis. Cell Cycle, 2010, 9(13): 2544-2547
76. Mercer T R, Dinger M E, Mattick J S. Long non-coding RNAs: insights into functions. Nat Rev Genet, 2009, 10(3): 155-159